Karyopharm files for bankruptcy, plans merger with Ayrmid
What it means
- What to watch: $KPTI is doing M&A; deals live or die on financing and approvals, which arrive long after the press release.
- How the stock is trading: $KPTI -68.28% in the latest session.
- Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Where the stock stands
$KPTI last traded at $0.21, -68.28% on the session. That puts it 98% shy of its 52-week high of $10.99 and -32.3% clear of its low of $0.31 — within a tenth of its 52-week low. Over the year it has ranged 3445% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $KPTI page.
How much coverage it is getting
This is the only story Wook has logged on $KPTI in the last 30 days — a quiet name that just got a headline. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$KPTI earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
For the receipts, the $KPTI page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $KPTI is from its high, or how this week's coverage compares.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bearish at medium severity because of “bankruptcy” in the wording, with nothing on the bullish side to offset it. It was matched to $KPTI. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 2, 2026. $KPTI has moved -27.86% ($0.29 to $0.21). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.